Continuous Glucose Monitoring (CGM) Market : Key Drivers, Regional Insights & Forecast to 2033
Global Continuous Glucose Monitoring (CGM) Market – Size, Share, Trends, Growth, and Forecast 2025-2033
Market Overview
The Global Continuous Glucose Monitoring (CGM) Market is poised for substantial expansion over the next decade. Estimated at USD 6.82 billion in 2024, the market is projected to reach approximately USD 14.1 billion by 2033, growing at a robust CAGR of 8.41% during the forecast period. The surge is driven by increasing diabetes prevalence, technological advancements in CGM systems, and the global push for better chronic disease management solutions.
Do you want to visit Char Dham? Char Dham Travel Agent is the best place to plan your Char Dham tour. You can book the tour from here.
What is Continuous Glucose Monitoring (CGM)?
Continuous Glucose Monitoring (CGM) is a breakthrough in diabetes management that provides real-time glucose level tracking through a minimally invasive sensor placed under the skin. These sensors measure glucose in interstitial fluid and transmit data to a receiver or smartphone, offering continuous feedback. CGM systems help patients avoid hyperglycemia and hypoglycemia by enabling timely medical interventions. Widely adopted in both homecare and clinical settings, CGMs are becoming central to the management of Type 1 and insulin-dependent Type 2 diabetes.
Market Growth Drivers
Would you like to visit Indiar? A tour operator in India is the best place to plan your tour. You can book a tour from here.
1. Rising Global Diabetes Prevalence
The dramatic rise in both Type 1 and Type 2 diabetes cases globally is a key driver. According to IDF statistics:
- 537 million adults (aged 20–79) were living with diabetes in 2021.
- This figure is expected to rise to 643 million by 2030 and 783 million by 2045.
- Over 14% of adults globally were affected by diabetes in 2022, up from 7% in 1990.
This growing patient base is propelling the demand for real-time, accurate glucose monitoring systems like CGMs.
Would you like to visit Haridwar? Travel agents in Haridwar are the best place to plan your trip. You can book your tour right here.
2. Technological Innovations in CGM Systems
Continuous advancements are enhancing device performance, user comfort, and integration with digital platforms. Key innovations include:
- Improved sensor accuracy and longevity.
- Seamless smartphone compatibility.
- Integration with automated insulin delivery systems.
- Real-time alerts and predictive analytics.
In August 2024, Abbott partnered with Medtronic to integrate FreeStyle Libre technology with Medtronic’s insulin systems—setting a precedent for future CGM device evolution.
3. Shift Towards Homecare and Personalized Monitoring
The rising preference for home-based healthcare solutions has increased the use of CGM devices. These tools:
- Eliminate the need for frequent hospital visits.
- Support remote monitoring by healthcare professionals.
- Promote patient empowerment and proactive disease management. This trend is especially significant for elderly and pediatric diabetic populations.
Key Market Challenges
1. High Cost of Devices
The affordability of CGM systems remains a barrier, especially in low- and middle-income regions. Ongoing costs for sensors and transmitters can be substantial for uninsured patients, limiting market penetration.
2. Accuracy and Calibration Concerns
Despite significant improvements, discrepancies in sensor readings and occasional calibration requirements may impact user trust and clinical adoption. Ongoing R&D is focused on enhancing accuracy and reducing manual interventions.
Related Report
- Aerospace 3D Printing Market Global Forecast Report by Offerings (Materials, Printers, Software, Services), Printing Technology (Direct Metal Laser Sintering (DMLS), Fused Deposition Modeling (FDM), Continuous Liquid Interface Production (CLIP), Selective Laser Melting (SLM), Selective Laser Sintering (SLS), Others), Platform (Aircraft, Unmanned Ariel Vehicles (UAV), Spacecraft), Application (Engine Component, Space Component, Structural Component), End Use (OEM, MRO), Countries and Company Analysis 2025-2033
- China Diabetes Devices Market Forecast Report by Types (Self-Monitoring Devices, Continuous Glucose-Monitoring Devices, Insulin Pumps, Insulin Pens), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies) and Company Analysis 2024-2032
- Switzerland Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis
Segment Analysis
By Component
• Sensors
Sensors are the most critical component of a CGM system, continuously measuring glucose levels. Advancements are improving:
- Sensor lifespan
- Comfort and wearability
- Minimal calibration
Manufacturers are investing in long-lasting, low-cost, and accurate sensors to improve user adherence and expand market reach.
• Transmitters
Transmitters relay glucose data from sensors to display devices. Emphasis is on:
- Miniaturization
- Battery life
- Wireless connectivity
Technological integration with wearables and cloud platforms is a key trend.
• Receivers
Receivers interpret and present glucose data to the user. Trends include:
- Use of smartphone apps
- Integration with health cloud ecosystems
- Improved user interface and trend analytics
Receivers are expected to become more sophisticated, especially in premium CGM systems.
By End User
• Hospitals
Hospitals use CGMs to manage glucose levels in critical care, post-operative recovery, and inpatient diabetes management. Benefits include:
- Real-time monitoring
- Improved clinical decision-making
- Reduction in glucose variability in ICU settings
• Homecare Settings
Homecare represents the fastest-growing end-user segment due to:
- Aging population
- Growing demand for remote monitoring
- Emphasis on cost-effective chronic care management
• Others
This includes outpatient clinics, diabetes care centers, and athletic institutions, which are beginning to adopt CGM for specialized use cases, including performance tracking.
Regional Insights
United States
The U.S. leads the global CGM market due to:
- High diabetes prevalence
- Advanced healthcare infrastructure
- Broad insurance coverage
- Strong government support for digital health
CDC estimates show 98 million adults in the U.S. have prediabetes, underlining the urgent need for proactive monitoring solutions like CGMs.
Germany
Germany represents the largest CGM market in Europe, supported by:
- Robust insurance reimbursement policies
- High healthcare awareness
- Government initiatives in diabetes management education
India
India’s CGM market is booming owing to:
- Its massive diabetic population
- Rising health consciousness
- Expansion of low-cost CGM options
- Increased use of telemedicine and mobile health platforms
The partnership between Dario Health and Dexcom in 2023 showcases this momentum.
Brazil
Brazil is witnessing increased CGM adoption despite pricing challenges. Growth is driven by:
- Government incentives
- Collaborations with global tech firms, like the Molex and GlucoModicum partnership on needle-free CGM technology.
UAE
The UAE market benefits from:
- High diabetes incidence
- Government initiatives promoting digital health
- Integration with AI-powered wellness apps like PureHealth’s Pura, emphasizing personalized care
Competitive Landscape
Major Companies Covered
- Abbott Laboratories
- Roche
- DexCom Inc.
- Medtronic Plc.
- Tandem Diabetes Care
- Senseonics Holdings Inc.
- Ypsomed Holding AG
- i-Sens Inc.
These players are engaged in intense R&D, strategic partnerships, and regional expansion to maintain competitiveness in the evolving CGM market.
Market Segmentation
By Component
- Sensors
- Transmitters
- Receivers
By End User
- Hospitals
- Homecare Settings
- Others
By Geography
- North America: United States, Canada
- Europe: Germany, UK, France, Italy, Spain, Netherlands, etc.
- Asia-Pacific: China, Japan, India, South Korea, Australia, etc.
- Latin America: Brazil, Mexico, Argentina
- Middle East & Africa: South Africa, Saudi Arabia, UAE
Report Coverage & Customization
- Historical Period: 2020–2024
- Forecast Period: 2025–2033
- Data Format: PDF, Excel (editable PPT/Word available)
- Customization: 20% Free
- Post-Sale Support: 1 Year
Key Questions Answered
- What is the projected market size by 2033?
- What are the top market growth drivers and barriers?
- Which region leads the global CGM market?
- How are advancements in CGM technology shaping patient outcomes?
- What role do homecare and remote monitoring play in this market?
- Who are the leading companies, and what are their strategies?
